Company intelligence / Profile preview
CliPS BnC
- Ownership
- Private
- Development stage
- Other
Overview
CliPS BnC is a South Korean biotechnology company that operates as a clinical-based product development platform, specializing in the development of vaccines and cell therapies. The company leverages its expertise as a Contract Research Organization (CRO) to accelerate the development of its internal pipeline, which includes a clinical-stage vaccine for adult tuberculosis and various cell therapy candidates. CliPS BnC focuses on addressing unmet medical needs in infectious diseases and oncology through strategic partnerships and advanced research. By integrating clinical trial management with drug discovery, the company aims to streamline the path from laboratory research to commercialization.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineCell therapy
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on CliPS BnC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CliPS BnC.